bioRxiv Science⌕ Search

Biology subjects

Evans, R. T.

Publications and source records attributed to Evans, R. T..

2 recordsLinked to original sources

Global analysis of the cold-shock response in the model antibiotic producing actinomycete, Streptomyces coelicolor A3(2)

Cold-shock adaptation is essential for the survival of soil-dwelling sessile streptomycetes exposed to fluctuating environmental temperatures, yet the precise regulatory mechanisms underlying this response remain poorly understood. Here, we investigated the global transcriptional and translational responses of the model actinomycete, Streptomyces coelicolor A3(2), to cold-shock using integrated RNA-seq and polysome profiling. Cold-shock treatment in minimal liquid medium triggered significant transcriptional changes in 811 genes. Notably, three operons, encoding a CspA homologue, a DEAD-box helicase, and a cystathionine-{beta}-synthase (CBS) domain-containing protein and/or a protein of unknown function (SCO5921-SCO5918, SCO4684-SCO4686, and SCO3731-SCO3733) were identified as central players of the cold-shock response, exhibiting up to 2,000-fold transcriptional induction. Systems-level transcriptomic analysis further revealed the cold-shock induced activation of pathways associated with gluconeogenesis, coenzyme A metabolism, phenylacetate degradation, lipid raft remodelling, and extracellular functions, pointing to extensive metabolic reprogramming coordinated with membrane adaptation during cold acclimation. Polysome profiling unveiled strong translational potentiation of operonic genes downstream from the promoter proximal cspA homologue genes, a process potentially mediated by RNA secondary structures that overlap ribosome binding sites (RBSs). The pronounced induction of DEAD-box RNA helicases and CspA RNA chaperones is presumed to reflect their critical requirement for resolving excessive nucleic acid secondary structures inherent to the high G+C content genome of Streptomyces (>73% G+C), including the RBS-masking stem-loops within their own operons. Together, this study provides a comprehensive, system-level understanding of cold-shock adaptation in Streptomyces, highlighting a multi-layered regulatory architecture that couples metabolic reprogramming with RNA structure-dependent translational control to mitigate thermal stress. IMPORTANCEThis study characterizes the cold-shock response of the model actinomycete, S. coelicolor A3(2), for the first time at both the transcriptome and translatome levels. Combined with a machine-learning based iModulon framework, our findings provide critical insights on both metabolic adaptation and multi-layered regulatory mechanisms, including transcriptional networks and RNA structure-dependent translational control. Beyond advancing our fundamental understanding of cold acclimation in Streptomyces, we identified several putative cis-acting regulatory elements within the intergenic regions between the primary cold-shock genes (SCO4684 and SCO5921) and their downstream DEAD-box helicase-encoding genes. These regulatory elements, coupled with the exceptionally robust transcriptional and translational induction of the core cold-shock operons, significantly expands the synthetic biology toolkit for Streptomyces. Ultimately, these molecular components hold substantial potential for exploitation in optimizing and manipulating cryptic antibiotic biosynthetic gene clusters within this bacterial genus of considerable industrial importance.

genomics↗

ASPYRE-Lung: Validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in tissue

Genomic variant testing of tumors is a critical gateway for patients to access the full potential of personalized oncology therapeutics. Current methods such as next-generation sequencing are costly and challenging to interpret, while PCR assays are limited in the number of variants they can cover. We developed ASPYRE(R) (Allele-Specific PYrophosphorolysis REaction) technology to address the urgent need for rapid, accessible and affordable diagnostics informing actionable genomic target variants of a given cancer. The targeted ASPYRE-Lung panel for non-small cell carcinoma covers 114 variants in 11 genes (ALK, BRAF, EGFR, ERBB2, KRAS, RET, ROS1, MET & NTRK1/2/3) to robustly inform clinical management. The assay detects single nucleotide variants, insertions, deletions, and gene fusions from tissue-derived DNA and RNA simultaneously. We tested the limit of detection, specificity, analytical accuracy and analytical precision of ASPYRE-Lung using FFPE lung tissue samples from patients with non-small cell lung carcinoma, variant-negative FFPE tissue from healthy donors, and FFPE-based contrived samples with controllable variant allele fractions. The sensitivity of ASPYRE-Lung was determined to be [≤] 3% variant allele fraction for single nucleotide variants and insertions or deletions, 100 copies for fusions, and 200 copies for MET exon 14 skipping. The specificity was 100% with no false positive results. The analytical accuracy test yielded no discordant calls between ASPYRE-Lung and expected results for clinical samples (via orthogonal testing) or contrived samples, and results were replicable across operators, reagent lots, runs, and real-time PCR instruments with a high degree of precision. The technology is simple and fast, requiring only four reagent transfer steps using standard laboratory equipment (PCR and qPCR instruments) with analysis via a cloud-based analysis algorithm. The ASPYRE-Lung assay has the potential to be transformative in facilitating access to rapid, actionable molecular profiling of tissue for patients with non-small cell carcinoma.

cancer biology↗